A New Frontier to Fight This Hair-Loss Disease
Copy link
Caption
Alopecia areata, an autoimmune disease in which patients lose hair in random patches, impacts 2 percent of people globally, yet there are no FDA-approved treatments. But promising options are emerging.
By Ian Graber-Stiehl
Copy link
WHY YOU SHOULD CARE
Because this disease affects 2 percent of people globally and might be on the verge of its first effective treatment.
By Ian Graber-Stiehl
Alopecia areata, an autoimmune disease in which patients lose hair in random patches, impacts 2 percent of people globally, yet there are no FDA-approved treatments. People with the condition are also more prone to depression.